According to Samsung Biologics 's latest financial reports the company's total assets are C$17.34 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | C$16.45 B | -7.8% |
2022-12-31 | C$17.84 B | 109.05% |
2021-12-31 | C$8.53 B | 13.22% |
2020-12-31 | C$7.53 B | 12.92% |
2019-12-31 | C$6.67 B | -8.51% |
2018-12-31 | C$7.29 B | -13.85% |
2017-12-31 | C$8.47 B | 0.87% |
2016-12-31 | C$8.39 B | 19.38% |
2015-12-31 | C$7.03 B | 389.73% |
2014-12-31 | C$1.43 B |